Do Crescents Mean Rapidly Progressive IgA Nephropathy?

No, having crescents on your kidney biopsy does not automatically mean you have rapidly progressive IgA nephropathy (RPGN) or severe IgA Nephropathy (IgAN). A crescent is a specific pattern of injury seen under a microscope in the filtering units of your kidney (glomeruli). While crescents often reflect recent or active glomerular injury, RPGN is a clinical diagnosis based on how quickly your kidney function is actually declining over time in blood tests and the clinical course, not just what the biopsy shows ^[1][2].

Similarly, “severe IgAN” is not defined by one biopsy feature. Doctors assess overall severity by looking at your entire clinical picture, including your kidney function trend, sustained protein in the urine, blood pressure, and chronic scarring on the biopsy ^[3][4].

What the Biopsy Tells You (and What It Doesn’t)

When a pathologist looks at your biopsy, they use the Oxford MEST-C classification to describe different types of tissue damage. The “C” stands for crescents:

• C0: No cellular or fibrocellular crescents seen.
• C1: Crescents are present in fewer than 25% of the glomeruli ^[5][6].
• C2: Crescents are present in 25% or more of the glomeruli ^[5][6].

While a C1 or C2 score tells your doctor there has been glomerular injury, the pathologist’s full report will detail whether these crescents are cellular (active), fibrocellular, or fibrous (chronic scarring). International guidelines explicitly state that the presence or number of crescents alone should not be used to predict your overall disease progression ^[4].

How RPGN is Actually Diagnosed

Rapidly progressive IgA nephropathy (RPGN) is defined by a rapid loss of kidney function. In clinical guidelines, RPGN is operationally defined as a 50% or greater drop in your estimated glomerular filtration rate (eGFR) over 3 months or less ^[1].

However, one low eGFR value is not enough to diagnose RPGN. Your doctor must look at serial laboratory tests and confirm the decline after ruling out other reversible causes, such as dehydration, acute infections, or medication side effects ^[1][3].

Why Your eGFR Trajectory and Urine Matter

Because crescents alone do not tell the whole story, your care team must look at your overall clinical picture:

• Kidney Function Trajectory (eGFR): Your doctor will track your eGFR over multiple visits. A patient might have crescents on a biopsy but maintain stable or only slowly declining kidney function ^[7][8].
• Urine Findings: Glomerular injury often causes abnormalities in your urine, such as high levels of protein (proteinuria) or red blood cells (hematuria) ^[9][10]. Persistent proteinuria is an important marker for treatment and prognosis ^[11]. While hematuria can fluctuate, the level of blood in your urine does not by itself measure the rate of kidney decline ^[12]. Notably, dangerous kidney function decline can be clinically silent, meaning you might not have obvious symptoms ^[2].

How Treatment Differs

Because the presence of crescents does not automatically equal RPGN, treatment approaches are different:

• Crescents without rapid eGFR loss: If your biopsy shows crescents but your kidney function is relatively stable, your doctor will likely focus on an individualized plan of optimized supportive care ^[3][13]. This includes strict blood pressure control, individualized dietary changes (often sodium reduction with the help of a renal dietitian), and medications to protect the kidneys. Common medications include ACE inhibitors or ARBs (which are alternatives, not used together), and sometimes SGLT2 inhibitors ^[13]. Depending on your overall risk, persistent proteinuria, and eGFR, other targeted therapies may also be considered ^[13]. Heavy immunosuppression is generally avoided based on the C-score alone because the risks of severe infections and toxicity often outweigh the benefits ^[4][14]. Never start, stop, or combine kidney medications without consulting your clinician.
• True RPGN: If serial tests confirm clinical RPGN after urgent nephrology evaluation, doctors may consider aggressive immunosuppressive treatments, such as high-dose corticosteroids combined with cyclophosphamide ^[15][16]. This is a specialized, guideline-supported consideration because the immediate threat of kidney failure must be carefully weighed against the substantial risks of the treatment, which include severe infections, fertility issues, and medication toxicity ^[16][14].

Safety Warning: When to Seek Immediate Care
Kidney function decline is often silent, so it is crucial to keep up with your lab work. Contact your nephrology team promptly if your routine labs show a rapid decline in eGFR. Seek urgent medical care if you experience markedly reduced urine output, rapidly worsening swelling, new shortness of breath, confusion, or severe chest pain.

What to Bring to Your Appointment
To get the most out of your consultation, bring:

• A copy of your full kidney biopsy pathology report
• A dated list of your past creatinine, eGFR, and urine protein results
• A complete list of all current medications, over-the-counter drugs, and herbal supplements
• Notes on any recent illnesses or changes in symptoms